InvestorsHub Logo
Followers 37
Posts 6608
Boards Moderated 3
Alias Born 05/06/2014

Re: Cbdpotential post# 103

Thursday, 11/11/2021 6:21:19 AM

Thursday, November 11, 2021 6:21:19 AM

Post# of 477
LINK:

https://www.wsj.com/articles/aipharma-signs-binding-agreement-to-sell-to-aditxt-inc-nasdaq-adtx-aipharma-is-the-rights-holder-of-antiviral-tablet-avigan-reeqonus-qifenda-that-has-treated-over-1-5m-covid-19-patients-since-the-outbreak-01633452430?tesla=y


From the 10/5/2021 PR:

" Consortium partner Appili Therapeutics is running a global Phase 3 trial evaluating Avigan/Reeqonus as an oral at-home therapy for COVID-19 and recently announced completion of patient enrollment with top line data expected within 45 days. Appili has also planned a Phase 3 post-exposure prophylaxis study designed to evaluate Avigan/Reeqonus for the prevention of COVID-19 when given to asymptomatic individuals who have had direct exposure to an infected person. Appili expects to initiate following successful completion of the treatment study. "

That would be appox. 19th this month

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADTX News